Skip to main content
OpenTrials
Completed

NCT Number: NCT02885129

Development of the General Scale Observance for Chronic Diseases

The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15.

The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Diseases Chronic Disease Disease Attributes Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Central hospital

Nancy, 54000, France

About this study

During a routine appointment (D0), the patient filled a newsletter and a questionnaire to complete.

The doctor collects medical informations for the case report form.

At the end of the first consultation (D0), an additional EGOMAC scale and a stamped envelope is delivered to the patient by asking him to fill that scale to 15 days and return it by Post Office (reproducibility study).

Finally, a new scale will be addressed to the patient at the end of 3 months, which will return by Post Office too (stability study).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient age of 18 years
  • from routine patient counseling
  • with at least one of these diseases : heart failure, hypertension, coronary disease, type 2 diabetes, osteoarthritis of the knee or hip, osteoporosis, inflammatory rheumatism (rheumatoid arthritis, spondyloarthropathy), cancer ( with only non-hormonal oral anti cancer treatments) and HIV.
  • patient can read the French language in order to complete the self -administered questionnaire
  • patient agreeing to participate in the study

Exclusion criteria

  • patient treated for more than 3 conditions mentioned in the inclusion criteria (
  • patient receiving no drug prescription or recommendation of lifestyle or diet (for example consultationpurely diagnostic ).

Treatment and study plan

Primary outcomes

  1. EGOMAC questionnaire

    Time frame: baseline

  2. Change in EGOMAC questionnaire

    Time frame: 15 days

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

Development of the General Scale Observance for Chronic Diseases (EGOMAC)

Acronym: EGOMAC

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Aug 31, 2016
Registry last updated
Aug 16, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.